Joelia Maria Maria Costa Dias Ladeira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joelia Maria Maria Costa Dias Ladeira has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Adyléia Aparecida Dalbo Contrera Toro
Department of Pediatric, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
2 shared publications Amanda Miranda Ferreira
Universidade Estadual de Campinas
2 shared publications- Amanda Miranda Ferreira
Department of Pediatric, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
2 shared publications - Milena Baptistella Grotta
Department of Pediatric, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
2 shared publications Olívia Zacas
Universidade Estadual de Campinas
2 shared publications- Olívia Zacas
Department of Pediatric, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 March 2026
- Vol. 61 (3) , e71541
The Role of Vitamin D in Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta-Analysis.
Vitamin D may modulate the inflammatory processes involved in asthma. To synthesize evidence on the association between serum 25-hydroxyvitamin D levels and asthma control, severity, pulmonary function, and inflammatory markers in children and adolescents. MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest until May 2025. Eligible studies enrolled participants aged 2-18 years with clinically diagnosed asthma and evaluated serum vitamin D levels in relation to asthma severity and/or control and pulmonary function parameters or type 2 inflammatory biomarkers. We included observational and randomized studies. The risk of bias for studies was assessed. Random-effects models estimated pooled outcomes. The heterogeneity was assessed using Cochran's Q and the I² statistic. Forty-one studies (7780 participants) were included; 25 contributed to meta-analyses. Children with asthma had significantly lower serum 25(OH)D levels than healthy controls (mean difference -4.89 ng/mL; 95% CI -7.38 to -2.40; p < 0.001). Severe asthma was associated with lower vitamin D compared with mild disease (-4.21 ng/mL; 95% CI -6.43 to -1.98; p = 0.0002). No significant difference was observed between controlled and uncontrolled asthma. Correlations with pulmonary function were weak and non-significant (FEV₁ r = 0.18; p = 0.08). Vitamin D showed a moderate inverse association with total IgE (r = -0.37; p = 0.02), but not with eosinophil counts or IL-10. Heterogeneity was high across analyses. Children with asthma exhibit lower serum vitamin D levels compared with healthy peers, and these levels are inversely associated with asthma severity and total IgE. No consistent associations were observed with pulmonary function or asthma control. Further research is needed to determine whether correcting vitamin D deficiency can improve clinical and immunologic outcomes in pediatric asthma.
- 1 March 2026
- Vol. 61 (3) , e71541
Open AccessThe Role of Vitamin D in Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta-Analysis.
Vitamin D may modulate the inflammatory processes involved in asthma. To synthesize evidence on the association between serum 25-hydroxyvitamin D levels and asthma control, severity, pulmonary function, and inflammatory markers in children and adolescents. MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest until May 2025. Eligible studies enrolled participants aged 2-18 years with clinically diagnosed asthma and evaluated serum vitamin D levels in relation to asthma severity and/or control and pulmonary function parameters or type 2 inflammatory biomarkers. We included observational and randomized studies. The risk of bias for studies was assessed. Random-effects models estimated pooled outcomes. The heterogeneity was assessed using Cochran's Q and the I² statistic. Forty-one studies (7780 participants) were included; 25 contributed to meta-analyses. Children with asthma had significantly lower serum 25(OH)D levels than healthy controls (mean difference -4.89 ng/mL; 95% CI -7.38 to -2.40; p < 0.001). Severe asthma was associated with lower vitamin D compared with mild disease (-4.21 ng/mL; 95% CI -6.43 to -1.98; p = 0.0002). No significant difference was observed between controlled and uncontrolled asthma. Correlations with pulmonary function were weak and non-significant (FEV₁ r = 0.18; p = 0.08). Vitamin D showed a moderate inverse association with total IgE (r = -0.37; p = 0.02), but not with eosinophil counts or IL-10. Heterogeneity was high across analyses. Children with asthma exhibit lower serum vitamin D levels compared with healthy peers, and these levels are inversely associated with asthma severity and total IgE. No consistent associations were observed with pulmonary function or asthma control. Further research is needed to determine whether correcting vitamin D deficiency can improve clinical and immunologic outcomes in pediatric asthma.
- Open Access
- 27 February 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (3)
The Role of Vitamin D in Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta‐Analysis
Context: Vitamin D may modulate the inflammatory processes involved in asthma. Objective: To synthesize evidence on the association between serum 25‐hydroxyvitamin D levels and asthma control, severity, pulmonary function, and inflammatory markers in children and adolescents. Data Sources: MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest until May 2025. Study Selection: Eligible studies enrolled participants aged 2–18 years with clinically diagnosed asthma and evaluated serum vitamin D levels in relation to asthma severity and/or control and pulmonary function parameters or type 2 inflammatory biomarkers. We included observational and randomized studies. Data Extraction: The risk of bias for studies was assessed. Random‐effects models estimated pooled outcomes. The heterogeneity was assessed using Cochran's Q and the I² statistic. Results: Forty‐one studies (7780 participants) were included; 25 contributed to meta‐analyses. Children with asthma had significantly lower serum 25(OH)D levels than healthy controls (mean difference −4.89 ng/mL; 95% CI −7.38 to −2.40; p < 0.001). Severe asthma was associated with lower vitamin D compared with mild disease (−4.21 ng/mL; 95% CI −6.43 to −1.98; p = 0.0002). No significant difference was observed between controlled and uncontrolled asthma. Correlations with pulmonary function were weak and non‐significant (FEV₁ r = 0.18; p = 0.08). Vitamin D showed a moderate inverse association with total IgE ( r = −0.37; p = 0.02), but not with eosinophil counts or IL‐10. Heterogeneity was high across analyses. Conclusions: Children with asthma exhibit lower serum vitamin D levels compared with healthy peers, and these levels are inversely associated with asthma severity and total IgE. No consistent associations were observed with pulmonary function or asthma control. Further research is needed to determine whether correcting vitamin D deficiency can improve clinical and immunologic outcomes in pediatric asthma.
- 27 February 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (3)
Open AccessThe Role of Vitamin D in Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta‐Analysis
Context: Vitamin D may modulate the inflammatory processes involved in asthma. Objective: To synthesize evidence on the association between serum 25‐hydroxyvitamin D levels and asthma control, severity, pulmonary function, and inflammatory markers in children and adolescents. Data Sources: MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest until May 2025. Study Selection: Eligible studies enrolled participants aged 2–18 years with clinically diagnosed asthma and evaluated serum vitamin D levels in relation to asthma severity and/or control and pulmonary function parameters or type 2 inflammatory biomarkers. We included observational and randomized studies. Data Extraction: The risk of bias for studies was assessed. Random‐effects models estimated pooled outcomes. The heterogeneity was assessed using Cochran's Q and the I² statistic. Results: Forty‐one studies (7780 participants) were included; 25 contributed to meta‐analyses. Children with asthma had significantly lower serum 25(OH)D levels than healthy controls (mean difference −4.89 ng/mL; 95% CI −7.38 to −2.40; p < 0.001). Severe asthma was associated with lower vitamin D compared with mild disease (−4.21 ng/mL; 95% CI −6.43 to −1.98; p = 0.0002). No significant difference was observed between controlled and uncontrolled asthma. Correlations with pulmonary function were weak and non‐significant (FEV₁ r = 0.18; p = 0.08). Vitamin D showed a moderate inverse association with total IgE ( r = −0.37; p = 0.02), but not with eosinophil counts or IL‐10. Heterogeneity was high across analyses. Conclusions: Children with asthma exhibit lower serum vitamin D levels compared with healthy peers, and these levels are inversely associated with asthma severity and total IgE. No consistent associations were observed with pulmonary function or asthma control. Further research is needed to determine whether correcting vitamin D deficiency can improve clinical and immunologic outcomes in pediatric asthma.
- Open Access
- 11 September 2023
- Published by Wiley
The Role of Vitamin D in the Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta-analysis
Background : Vitamin D may contribute to the balance in between regulatory and suppressive functions of T cells to modulate the inflammatory process in asthma. Objective: To assess serum vitamin D levels and their relationship with asthma control, asthma severity and its anti-inflammatory effect in children. Methods: This systematic review was based on articles published between 2009 and August 2022. Children under 18 years old with asthma were included. Results : The initial database search identified 2,015 manuscripts. Through screening identified only 25 eligible articles, but only eight studies met criteria for inclusion in the meta-analysis. The analysis revealed that in six studies involving 588 participants, mean 25-hydroxyvitamin D levels were lower in children with uncontrolled asthma compared to those with controlled asthma, with a mean difference of -5.07 (-8.57, -1.57) and a high rate of heterogeneity I 2 = 89%. In five studies comprising 362 patients, the relationship between vitamin D and asthma severity was assessed. Lower levels of vitamin D were associated with a higher risk of severe asthma in children, with a mean difference of -6.00 (-8.09, -3.90) and substantial heterogeneity (90%, p Conclusion : Vitamin D plays a critical role in reducing asthma attacks. However, more randomized studies are necessary for a thorough evaluation and definitive recommendation for vitamin D supplementation.
- 11 September 2023
- Published by Wiley
Open AccessThe Role of Vitamin D in the Severity and Control of Asthma in Children and Adolescents: A Systematic Review and Meta-analysis
Background : Vitamin D may contribute to the balance in between regulatory and suppressive functions of T cells to modulate the inflammatory process in asthma. Objective: To assess serum vitamin D levels and their relationship with asthma control, asthma severity and its anti-inflammatory effect in children. Methods: This systematic review was based on articles published between 2009 and August 2022. Children under 18 years old with asthma were included. Results : The initial database search identified 2,015 manuscripts. Through screening identified only 25 eligible articles, but only eight studies met criteria for inclusion in the meta-analysis. The analysis revealed that in six studies involving 588 participants, mean 25-hydroxyvitamin D levels were lower in children with uncontrolled asthma compared to those with controlled asthma, with a mean difference of -5.07 (-8.57, -1.57) and a high rate of heterogeneity I 2 = 89%. In five studies comprising 362 patients, the relationship between vitamin D and asthma severity was assessed. Lower levels of vitamin D were associated with a higher risk of severe asthma in children, with a mean difference of -6.00 (-8.09, -3.90) and substantial heterogeneity (90%, p Conclusion : Vitamin D plays a critical role in reducing asthma attacks. However, more randomized studies are necessary for a thorough evaluation and definitive recommendation for vitamin D supplementation.
- Open Access
- 16 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (50) , e31457
The role of vitamin D in the severity and control of asthma in children and adolescents: A protocol for systematic review and meta-analysis
Background: Vitamin D plays an important role in the immune system and consequently in the inflammatory process of asthma. It acts directly on the regulation of helper T lymphocytes 1 (Th1) and helper T lymphocytes 2 (Th2) cells, and regulatory T lymphocytes. Evidence shows that vitamin D acts on dendritic cells, raising inflammatory mediators and increasing the imbalance between Th1, Th2, and helper T lymphocytes 17 (Th17). Evidence shows a strong association between vitamin D levels and asthma incidence, especially in patients with severe and uncontrolled asthma. Methods: A systematic and comprehensive search will be performed using four main databases, PubMed, EMBASE, Cochrane Library, and Web of Science. Articles will be searched from the earliest available time to august 2022. The studied population will be composed of children and or adolescents with asthma. From the data obtained, all articles found will be transferred to the Rayyan platform. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Checklist (PRISMA P-2020). In addition, if sufficient data are available, a meta-analysis will be conducted. Two independent reviewers will conduct the studies selection, data extraction, and risk of bias assessment. The outcome measures will be to analyze the serum levels of vitamin D in patients with asthma and to relate this hormone to the control and severity of the disease and its anti- inflammatory effect. Results: A systematic review will provide better knowledge regarding vitamin D and its role in the severity and control of asthma. Conclusions: The findings of this study will be published in a peer-reviewed journal.
- 16 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (50) , e31457
Open AccessThe role of vitamin D in the severity and control of asthma in children and adolescents: A protocol for systematic review and meta-analysis
Background: Vitamin D plays an important role in the immune system and consequently in the inflammatory process of asthma. It acts directly on the regulation of helper T lymphocytes 1 (Th1) and helper T lymphocytes 2 (Th2) cells, and regulatory T lymphocytes. Evidence shows that vitamin D acts on dendritic cells, raising inflammatory mediators and increasing the imbalance between Th1, Th2, and helper T lymphocytes 17 (Th17). Evidence shows a strong association between vitamin D levels and asthma incidence, especially in patients with severe and uncontrolled asthma. Methods: A systematic and comprehensive search will be performed using four main databases, PubMed, EMBASE, Cochrane Library, and Web of Science. Articles will be searched from the earliest available time to august 2022. The studied population will be composed of children and or adolescents with asthma. From the data obtained, all articles found will be transferred to the Rayyan platform. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Checklist (PRISMA P-2020). In addition, if sufficient data are available, a meta-analysis will be conducted. Two independent reviewers will conduct the studies selection, data extraction, and risk of bias assessment. The outcome measures will be to analyze the serum levels of vitamin D in patients with asthma and to relate this hormone to the control and severity of the disease and its anti- inflammatory effect. Results: A systematic review will provide better knowledge regarding vitamin D and its role in the severity and control of asthma. Conclusions: The findings of this study will be published in a peer-reviewed journal.
- Open Access
- 20 December 2021
- Published by Springer Nature in Research Square
What is the Role of Vitamin D in the Severity and Control of Asthma in Children and Adolescents: a Protocol for a Systematic Review
Background: Vitamin D plays an important role in the immune system and consequently in the inflammatory process of asthma. It acts directly on the regulation of Th1 and Th2 cells and regulatory T lymphocytes. Evidence shows that vitamin D can act on dendritic cells, raising inflammatory mediators and increasing the imbalance between Th1, Th2, and Th17. Understanding the link between vitamin D and inflammatory processes in the control and severity of asthma is important for the existence of specific therapies. Objective: We aim to synthesize the scientific evidence about the role of Vitamin D in the control and severity of asthma in pediatric patients by a systematic review. Methods: A systematic and comprehensive search will be performed using MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest. From the data obtained, all the articles found will be transferred to the Rayyan platform. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist (PRISMA-2020). Additionally, if sufficient data are available, a meta-analysis will be conducted.Discussion: The ability of vitamin D to act in the immune system with a direct action on the inflammatory asthma cascade, allows for a better understanding of the disease. This will lead to better asthma management, and, consequently, to help in controlling the disease. The conduction of a systematic review will bring better knowledge about vitamin D and its role in the pathophysiology of asthma Systematic review registration:This protocol has been registered in the PROSPERO and the registration number is CRD42021221638.
- 20 December 2021
- Published by Springer Nature in Research Square
Open AccessWhat is the Role of Vitamin D in the Severity and Control of Asthma in Children and Adolescents: a Protocol for a Systematic Review
Background: Vitamin D plays an important role in the immune system and consequently in the inflammatory process of asthma. It acts directly on the regulation of Th1 and Th2 cells and regulatory T lymphocytes. Evidence shows that vitamin D can act on dendritic cells, raising inflammatory mediators and increasing the imbalance between Th1, Th2, and Th17. Understanding the link between vitamin D and inflammatory processes in the control and severity of asthma is important for the existence of specific therapies. Objective: We aim to synthesize the scientific evidence about the role of Vitamin D in the control and severity of asthma in pediatric patients by a systematic review. Methods: A systematic and comprehensive search will be performed using MEDLINE PubMed, BIREME, EBSCOhost, Scopus, Web of Science, EMBASE, Cochrane Library, and ProQuest. From the data obtained, all the articles found will be transferred to the Rayyan platform. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist (PRISMA-2020). Additionally, if sufficient data are available, a meta-analysis will be conducted.Discussion: The ability of vitamin D to act in the immune system with a direct action on the inflammatory asthma cascade, allows for a better understanding of the disease. This will lead to better asthma management, and, consequently, to help in controlling the disease. The conduction of a systematic review will bring better knowledge about vitamin D and its role in the pathophysiology of asthma Systematic review registration:This protocol has been registered in the PROSPERO and the registration number is CRD42021221638.